Horama's Series B Round

Horama raised a round of funding on November 08, 2017.

Horama, created in March 2014, is developing new gene therapies for the treatment of hereditary retinopathies pigmentosa, which are orphan ophthalmological diseases. Horama is a specialist in ophthalm…

Articles about Horama's Series B Round: